GlassScriptPhysician profile
Emma Loyfman
NPI 1174752091
$22,689.74
in general payments reported to CMS, 2019-2025
14 companies · $5,747 in 2025
The $5,747 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2020: $715 · 2021: $2,087 · 2022: $5,837 · 2023: $2,645 · 2024: $4,748 · 2025: $5,747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,800 · Food and Beverage: $4,346 · Travel and Lodging: $1,994 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,800.00 |
| Food and Beverage | $4,345.78 |
| Travel and Lodging | $1,993.70 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $17,853.40 | 2019-2025 | Myday Contact Lens, Biofinity Contact Lens, Cvi Contact Lens |
| Alcon Vision LLC | $1,502.41 | 2019-2025 | Total30, Precision 1, Precision7 |
| Bausch & Lomb Americas INC. | $1,351.41 | 2023-2025 | Infuse, Biotrue, Miebo |
| Johnson & Johnson Vision Care, INC. | $1,128.71 | 2019-2024 | Acuvue |
| Allergan, INC. | $222.84 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $184.30 | 2019-2020 | |
| Sight Sciences, INC. | $122.01 | 2019-2021 | |
| Glaukos Corporation | $115.23 | 2022 | |
| Abbvie INC. | $112.00 | 2022 | |
| Ivantis, INC | $35.91 | 2021 | |
| Iridex Corporation | $20.75 | 2021 | |
| Carl Zeiss Meditec, INC. | $15.63 | 2019 | |
| Oyster Point Pharma, INC. | $14.31 | 2022 | |
| Shire North American Group INC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Loyfman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.